Search clinical trials for: 99mTc-rhAnnexin V-128

Total 13 results

Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis

Carotid Artery Plaque

Canada
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

Rheumatoid Arthritis | Ankylosing Spondylitis

Switzerland
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer

Breast Cancer | Doxorubicin Induced Cardiomyopathy

Canada
Advanced Accelerator Applications
Atreus Pharmaceuticals Corporation

Completed

99mTc-rhAnnexin V-128: a First In Man Study in Healthy Volunteers

Healthy Adult Volunteers

Canada
Advanced Accelerator Applications

Terminated

99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis (Annexin 03)

Spondyloarthritis

United States
Institut National de la Santé Et de la Recherche...
Advanced Accelerator Applications

Terminated

Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis (AnnIE)

Thrombosis | Endocarditis

France
Assistance Publique - Hôpitaux de Paris

Withdrawn

99m Tc-ANNexin-V-128 Scintigraphy for the Identification of Complicated Carotid Atherosclerotic Plaques (ANNICA)

Carotid Atherosclerosis | Atherosclerotic Plaque
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Imaging of Peri-operative (periOP) Lung Injury

Acute Lung Injury | Chronic Obstructive Pulmonary Disease (COPD)

United States
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Influence of the 34C>T Variant in the AMPD1 Gene Ischemic Tolerance

AMPD | Ischemic Tolerance
Actavis Inc.

Completed

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions

Healthy

Canada
Actavis Inc.

Completed

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

Healthy

Canada
Novo Nordisk A/S

Completed

A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes

Healthy | Diabetes | Diabetes Mellitus, Type 1

Germany
Mount Vernon Cancer Centre at Mount Vernon Hospital

Unknown

Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma

Lymphoma

United Kingdom

Search clinical trials for: 99mTc-rhAnnexin V-128

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations